Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart H Ralston

Showing results (91-100 of 275) with videos related to

Pageof 28
Sort By:
Annals of the Rheumatic Diseases|May 8, 2025
Response to: Correspondence on 'Methotrexate continuation increases fracture risk in patients who sustained lower limb insufficiency fractures' by Dai et alBarbara Hauser, Andrew Merriman, Jonathan Foley, et al.
The Cochrane Database of Systematic Reviews|December 2, 2017
Bisphosphonates for Paget's disease of bone in adultsLuis Corral-Gudino, Adrian Jh Tan, Javier Del Pino-Montes, et al.
Journal of Medicinal Chemistry|December 8, 2006
Development and characterization of biphenylsulfonamides as novel inhibitors of bone resorptionIain R Greig, Aymen I Idris, Stuart H Ralston, et al.
Clinical Trials (London, England)|November 11, 2005
An integrated approach to consumer representation and involvement in a multicentre randomized controlled trialAnne L Langston, Marilyn McCallum, Marion K Campbell, et al.
Calcified Tissue International|May 8, 2025
Management of a Patient with Severe Osteogenesis Imperfecta Undergoing Laparoscopic CholecystectomySarah Scott, Helen Jordan, Laura Gill, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
Development of triarylsulfonamides as novel anti-inflammatory agentsIain R Greig, Emmanuel Coste, Stuart H Ralston, et al.
Calcified Tissue International|August 31, 2010
Risk of upper gastrointestinal tract events in risedronate users switched to alendronateStuart H Ralston, Tzuyung D Kou, Bettina Wick-Urban, et al.
Rheumatology International|March 15, 2021
A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary diseaseOwen Cronin, Olivia McKnight, Lindsay Keir, et al.
Calcified Tissue International|February 13, 2022
Communicating Absolute Fracture Risk Reduction and the Acceptance of Treatment for OsteoporosisKatherine A P Ralston, Jonathan Phillips, Amrey Krause, et al.
Calcified Tissue International|January 10, 2012
A class III semaphorin (Sema3e) inhibits mouse osteoblast migration and decreases osteoclast formation in vitroAlun Hughes, Jennifer Kleine-Albers, Miep H Helfrich, et al.
Pageof 28

Showing results (91-100 of 275) with videos related to

Sort By:
Pageof 28
Annals of the Rheumatic Diseases|May 8, 2025
Response to: Correspondence on 'Methotrexate continuation increases fracture risk in patients who sustained lower limb insufficiency fractures' by Dai et alBarbara Hauser, Andrew Merriman, Jonathan Foley, et al.
The Cochrane Database of Systematic Reviews|December 2, 2017
Bisphosphonates for Paget's disease of bone in adultsLuis Corral-Gudino, Adrian Jh Tan, Javier Del Pino-Montes, et al.
Journal of Medicinal Chemistry|December 8, 2006
Development and characterization of biphenylsulfonamides as novel inhibitors of bone resorptionIain R Greig, Aymen I Idris, Stuart H Ralston, et al.
Clinical Trials (London, England)|November 11, 2005
An integrated approach to consumer representation and involvement in a multicentre randomized controlled trialAnne L Langston, Marilyn McCallum, Marion K Campbell, et al.
Calcified Tissue International|May 8, 2025
Management of a Patient with Severe Osteogenesis Imperfecta Undergoing Laparoscopic CholecystectomySarah Scott, Helen Jordan, Laura Gill, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
Development of triarylsulfonamides as novel anti-inflammatory agentsIain R Greig, Emmanuel Coste, Stuart H Ralston, et al.
Calcified Tissue International|August 31, 2010
Risk of upper gastrointestinal tract events in risedronate users switched to alendronateStuart H Ralston, Tzuyung D Kou, Bettina Wick-Urban, et al.
Rheumatology International|March 15, 2021
A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary diseaseOwen Cronin, Olivia McKnight, Lindsay Keir, et al.
Calcified Tissue International|February 13, 2022
Communicating Absolute Fracture Risk Reduction and the Acceptance of Treatment for OsteoporosisKatherine A P Ralston, Jonathan Phillips, Amrey Krause, et al.
Calcified Tissue International|January 10, 2012
A class III semaphorin (Sema3e) inhibits mouse osteoblast migration and decreases osteoclast formation in vitroAlun Hughes, Jennifer Kleine-Albers, Miep H Helfrich, et al.
Pageof 28